BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 12379461)

  • 1. Oncogenic H-ras induces cyclin B1 expression in a p53-independent manner.
    Santana C; Ortega E; García-Carrancá A
    Mutat Res; 2002 Oct; 508(1-2):49-58. PubMed ID: 12379461
    [TBL] [Abstract][Full Text] [Related]  

  • 2. GADD45-induced cell cycle G2-M arrest associates with altered subcellular distribution of cyclin B1 and is independent of p38 kinase activity.
    Jin S; Tong T; Fan W; Fan F; Antinore MJ; Zhu X; Mazzacurati L; Li X; Petrik KL; Rajasekaran B; Wu M; Zhan Q
    Oncogene; 2002 Dec; 21(57):8696-704. PubMed ID: 12483522
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Loss of p53 induces M-phase retardation following G2 DNA damage checkpoint abrogation.
    Minemoto Y; Uchida S; Ohtsubo M; Shimura M; Sasagawa T; Hirata M; Nakagama H; Ishizaka Y; Yamashita K
    Arch Biochem Biophys; 2003 Apr; 412(1):13-9. PubMed ID: 12646262
    [TBL] [Abstract][Full Text] [Related]  

  • 4. p53 regulates a G2 checkpoint through cyclin B1.
    Innocente SA; Abrahamson JL; Cogswell JP; Lee JM
    Proc Natl Acad Sci U S A; 1999 Mar; 96(5):2147-52. PubMed ID: 10051609
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of the G2/M transition by p53.
    Taylor WR; Stark GR
    Oncogene; 2001 Apr; 20(15):1803-15. PubMed ID: 11313928
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association with Cdc2 and inhibition of Cdc2/Cyclin B1 kinase activity by the p53-regulated protein Gadd45.
    Zhan Q; Antinore MJ; Wang XW; Carrier F; Smith ML; Harris CC; Fornace AJ
    Oncogene; 1999 May; 18(18):2892-900. PubMed ID: 10362260
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TIS21/BTG2/PC3 is expressed through PKC-delta pathway and inhibits binding of cyclin B1-Cdc2 and its activity, independent of p53 expression.
    Ryu MS; Lee MS; Hong JW; Hahn TR; Moon E; Lim IK
    Exp Cell Res; 2004 Sep; 299(1):159-70. PubMed ID: 15302583
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of adriamycin-induced G2 arrest and its abrogation by caffeine in FL-amnion cells with or without p53.
    Minemoto Y; Gannon J; Masutani M; Nakagama H; Sasagawa T; Inoue M; Masamune Y; Yamashita K
    Exp Cell Res; 2001 Jan; 262(1):37-48. PubMed ID: 11120603
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Constitutive activation of cyclin B1-associated cdc2 kinase overrides p53-mediated G2-M arrest.
    Park M; Chae HD; Yun J; Jung M; Kim YS; Kim SH; Han MH; Shin DY
    Cancer Res; 2000 Feb; 60(3):542-5. PubMed ID: 10676633
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Requirement of Krüppel-like factor 4 in preventing entry into mitosis following DNA damage.
    Yoon HS; Yang VW
    J Biol Chem; 2004 Feb; 279(6):5035-41. PubMed ID: 14627709
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Krüppel-like factor 5 promotes mitosis by activating the cyclin B1/Cdc2 complex during oncogenic Ras-mediated transformation.
    Nandan MO; Chanchevalap S; Dalton WB; Yang VW
    FEBS Lett; 2005 Aug; 579(21):4757-62. PubMed ID: 16102754
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanisms of G2 arrest in response to overexpression of p53.
    Taylor WR; DePrimo SE; Agarwal A; Agarwal ML; Schönthal AH; Katula KS; Stark GR
    Mol Biol Cell; 1999 Nov; 10(11):3607-22. PubMed ID: 10564259
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of Ras-Ral pathway attenuates p53-independent DNA damage G2 checkpoint.
    Agapova LS; Volodina JL; Chumakov PM; Kopnin BP
    J Biol Chem; 2004 Aug; 279(35):36382-9. PubMed ID: 15208305
    [TBL] [Abstract][Full Text] [Related]  

  • 14. UCN-01: a potent abrogator of G2 checkpoint function in cancer cells with disrupted p53.
    Wang Q; Fan S; Eastman A; Worland PJ; Sausville EA; O'Connor PM
    J Natl Cancer Inst; 1996 Jul; 88(14):956-65. PubMed ID: 8667426
    [TBL] [Abstract][Full Text] [Related]  

  • 15. p53-independent induction of p21 (WAF1/CIP1), reduction of cyclin B1 and G2/M arrest by the isoflavone genistein in human prostate carcinoma cells.
    Choi YH; Lee WH; Park KY; Zhang L
    Jpn J Cancer Res; 2000 Feb; 91(2):164-73. PubMed ID: 10761703
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanism of ultraviolet B-induced cell cycle arrest in G2/M phase in immortalized skin keratinocytes with defective p53.
    Athar M; Kim AL; Ahmad N; Mukhtar H; Gautier J; Bickers DR
    Biochem Biophys Res Commun; 2000 Oct; 277(1):107-11. PubMed ID: 11027648
    [TBL] [Abstract][Full Text] [Related]  

  • 17. p53 is a NF-Y- and p21-independent, Sp1-dependent repressor of cyclin B1 transcription.
    Innocente SA; Lee JM
    FEBS Lett; 2005 Feb; 579(5):1001-7. PubMed ID: 15710382
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Negative regulation of Wee1 expression and Cdc2 phosphorylation during p53-mediated growth arrest and apoptosis.
    Leach SD; Scatena CD; Keefer CJ; Goodman HA; Song SY; Yang L; Pietenpol JA
    Cancer Res; 1998 Aug; 58(15):3231-6. PubMed ID: 9699647
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nuclear localization of cyclin B1 controls mitotic entry after DNA damage.
    Jin P; Hardy S; Morgan DO
    J Cell Biol; 1998 May; 141(4):875-85. PubMed ID: 9585407
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of Cdc2 feedback loop control in the DNA damage checkpoint in mammalian cells.
    Poon RY; Chau MS; Yamashita K; Hunter T
    Cancer Res; 1997 Nov; 57(22):5168-78. PubMed ID: 9371520
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.